Plenary Session V - Contemporary Debates in Neuromodulation

8:00 - 9:30 AM Sunday, Jan. 15

This session will discuss key areas of debate in neuromodulation. Specifically, it will explore the data for and against pre-implant trialing for spinal cord stimulation and intrathecal infusion therapy. Furthermore, it will explore the risks and benefits of staged deep brain stimulator system implantation.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Explain the rationale for trials in IDDS and the rationale for bypassing then when possible.
  • Describe the rationale for staging or not staging DBS.
  • Discuss the rationale for trials in SCS and the rationale for bypassing trials when possible.

Welcome

Ahmed Raslan, MD

Simon Thomson, MBBS

SCS: To Trial

John Markman, MD

SCS: No Need to Trial

Ashish Gulve, MD

IDDS: Pro Trial

Salim Hayek, MD

IDDS: Not to Trial

Sandy Christiansen, MD

Single-Staged DBS

Joshua Rosenow, MD

Staged DBS

Andre Machado, MD

Closing Discussion

Ahmed Raslan, MD

Simon Thomson, MBBS

Faculty:

Ahmed Raslan, MD

Simon Thomson, MBBS

John Markman, MD

Ashish Gulve, MD

Salim Hayek, MD

Sandy Christiansen, MD

Joshua Rosenow, MD FACS

Andre Machado, MD